Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation

Yoshitaka Kitamura, Kenji Suzuki, Satoshi Teramukai, Makoto Sonobe, Shinichi Toyooka, Yoshihisa Nakagawa, Hiroyasu Yokomise, Hiroshi Date, J. Arikura, M. Miyajima, N. Tsunooka, S. Ueda, S. Shiono, H. Ichimura, Y. Ohtaki, O. Kawashima, N. Takahashi, T. Iwata, T. Murakawa, Y. ShimadaH. Horio, H. Ishibashi, R. Kawachi, T. Omori, M. Naito, T. Hashimoto, R. Waseda, Y. Tsunezuka, N. Tanaka, T. Eguchi, H. Agatsuma, Y. Mizuno, S. Nishikawa, M. Isaka, H. Haneda, K. Narita, K. Okuda, Y. Kobayashi, Y. Terada, T. Takemoto, R. Nakajima, R. Kanzaki, J. Okami, Y. Kadota, N. Hanaoka, A. Hayashi, W. Nishio, Y. Takahashi, H. Nakamura, Y. Taniguchi, A. Yamashina, H. Yamamoto, Y. Miyata, M. Matsuura, T. Tanaka, N. Matsuura, H. Suehisa, S. S. Chang, T. So, T. Osaki, S. Takeo, M. Takenoyama, T. Miyazaki, T. Marutsuka, K. Yoshimoto, K. Kariatsumari, M. Yanagi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background The aim of this study was to clarify the outcomes of lung resection for lung cancer in patients with cardiac disease, especially coronary artery disease, in a large-scale multi-institutional cohort. Methods We retrospectively analyzed the data on 1,254 patients who underwent major lung resection for lung cancer and had been diagnosed with coronary stenosis, atrial fibrillation, or both, in 58 institutions in Japan between January 2009 and December 2011. The primary outcome was 90-day postoperative mortality or in-hospital death. Results Among the 1,254 patients, 902 (71.9%) and 452 patients (36.0%) were preoperatively diagnosed with coronary stenosis and atrial fibrillation, respectively, and 951 patients (75.8%) received antiplatelet therapy. Among the patients with coronary stents (n = 532; 42.4%), 204 (16.3%) received drug-eluting stents. The 90-mortality or in-hospital death rate was 2.6% (n = 32), including stent thrombosis (n = 1), thromboembolic events without stent thrombosis (n = 2), and bleeding events (n = 2). In the multivariate analyses, blood transfusion, history of cerebrovascular disease, amount of bleeding, and history of congestive heart failure were associated with a higher independent risk of 90-day mortality or in-hospital death (odds ratio, 9.400, 3.574, 2.827, and 2.945, respectively). Preoperative discontinuation of antiplatelet therapy was not associated with an independent risk of 90-day mortality or in-hospital death on univariate analysis. Conclusions Major lung resection for lung cancer in patients with coronary artery disease is feasible. Our study suggests that discontinuation of antiplatelet therapy may not increase postoperative complications in patients with coronary artery disease.

Original languageEnglish
Pages (from-to)432-440
Number of pages9
JournalAnnals of Thoracic Surgery
Volume103
Issue number2
DOIs
Publication statusPublished - Feb 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation'. Together they form a unique fingerprint.

  • Cite this

    Kitamura, Y., Suzuki, K., Teramukai, S., Sonobe, M., Toyooka, S., Nakagawa, Y., Yokomise, H., Date, H., Arikura, J., Miyajima, M., Tsunooka, N., Ueda, S., Shiono, S., Ichimura, H., Ohtaki, Y., Kawashima, O., Takahashi, N., Iwata, T., Murakawa, T., ... Yanagi, M. (2017). Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation. Annals of Thoracic Surgery, 103(2), 432-440. https://doi.org/10.1016/j.athoracsur.2016.08.077